Market Cap | ₹139Cr |
ROE | -0.11% |
P/E Ratio(TTM) | 0.00 |
EPS(TTM) | 0.00 |
P/B Ratio | 13.67 |
Dividend Yield | 0.00% |
Industry P/E | 22.75 |
Book Value | 10.35 |
Debt to Equity | 1.04 |
Face Value | 10 |
Parent Organisation | Shreekrishna Biotech Limited |
Managing Director | NA |
Founded | 1983 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Nalwa Sons Investments | NA (0.00%) | 73.34 | ||
Systematix Corporate Services | NA (0.00%) | 31.57 | ||
Fedders Holding | NA (0.00%) | 26.75 | ||
Prime Securities | NA (0.00%) | 22.95 |